Armata Pharmaceuticals, Inc.
ARMP
$1.91
-$0.10-4.98%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.53M | 2.60M | -5.48M | 8.99M | -25.02M |
| Total Depreciation and Amortization | 377.00K | 380.00K | 313.00K | 315.00K | 317.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -229.00K | -12.10M | -2.76M | -18.82M | 15.81M |
| Change in Net Operating Assets | -1.20M | 1.19M | -935.00K | -661.00K | -1.69M |
| Cash from Operations | -7.58M | -7.93M | -8.86M | -10.18M | -10.58M |
| Capital Expenditure | -99.00K | 77.00K | -340.00K | -1.37M | -250.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -99.00K | 77.00K | -340.00K | -1.37M | -250.00K |
| Total Debt Issued | 10.00M | 0.00 | 0.00 | 0.00 | 34.89M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 88.00K | 42.00K |
| Repurchase of Common Stock | -14.00K | 0.00 | -61.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.99M | 0.00 | -61.00K | 88.00K | 34.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.31M | -7.85M | -9.26M | -11.46M | 24.10M |